跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Lavtrim - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Lavtrim
Approved
STANDARD
Lavtrim
Medreich Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
49f7464176410c2a
Company
Medreich Limited
Type
Standard
Approval Details
Approval Id
49f7464176410c2a
Drug Approval Philippines Name
Lavtrim
Product Name
Lavtrim
Registration Number
DRP-6869
Brand Name
Lavtrim
Generic Name
Trimetazidine dihydrochloride
Dosage Form
Modified-Release Tablet
Dosage Strength
35mg
Manufacturer
Medreich Limited
Importer
Sandoz Philippines Corporation
Distributor
Sandoz Philippines Corporation
Issuance Date
26 May 2022
Expiry Date
14 October 2026
Pharmacologic Category
Anti-anginal
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
49f7464176410c2a
Type
Standard
Back to Philippines FDA Approvals